Novo Nordisk (NVO) on Tuesday announced that it is enabling select telehealth providers to offer Wegovy, expanding access to ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...

LifeMD shares surged 22% after announcing plans to offer access to semaglutide, which is marketed as Wegovy to treat obesity, through NovoCare Pharmacy. Shares were trading around $7.49. The stock is ...

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy. | Novo Nordisk and Hims & Hers have struck a truce after sparring over ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients are found in: The drug products were in shortage since 2020. The FDA had ...

Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...